| Literature DB >> 34485938 |
Philippe Chouvarine1, Georg Hansmann1,2.
Abstract
Total RNA sequencing allows capturing of long non-coding and circular RNA along with mRNA. Additional sequencing of micro RNA (miRNA), using libraries with shorter fragments, provides the means to characterize miRNA-driven transcriptional regulation. Here, we present a protocol for processing total RNA and miRNA sequencing data to quantify circular RNA, long non-coding RNA, mRNA, and miRNA. Further, the protocol combines the quantification data with miRNA target annotation to construct likely transcriptional regulatory networks, which can be validated in the subsequent studies. For complete details on the use and execution of this protocol, please refer to Chouvarine et al. (2021).Entities:
Keywords: Bioinformatics; RNAseq; Systems biology
Mesh:
Substances:
Year: 2021 PMID: 34485938 PMCID: PMC8403681 DOI: 10.1016/j.xpro.2021.100769
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1Principle component analysis (PCA) of individual samples allows finding potential outlier samples
(A) PCA graph of the first three components with the outlier (Control.7).
(B) PCA graph of the first three components after removal of the outlier.
Figure 2An example of competing endogenous RNA network with functional annotation labels
The network appearance is customizable in Cytoscape using the data obtained by following the steps described in this protocol.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Human RV tissue (10–50 mg) was used for total RNA and miRNA extraction according to the TRIzol protocol (TRIzol, Life Technologies). | ( | N/A |
| RNAlater®-ICE Frozen Tissue Transition Solution | Ambion | Cat. No. AM7030 |
| TRIzol™ Reagent | Invitrogen | Cat. No. 15596026 |
| Total RNA sequencing | ( | Controlled access via National Register for Congenital Heart Defects, Berlin, Germany ( |
| Total RNA sequencing (alternative dataset for testing) | ( | SRA: SRP298758 |
| miRNA sequencing | ( | Controlled access via National Register for Congenital Heart Defects, Berlin, Germany ( |
| miRNA sequencing (alternative dataset for testing) | ( | SRA: SRP298758 |
| FastQC (V0.10.1) | Unpublished | |
| MultiQC (v1.10.1) | ( | |
| BWA (0.7.12-r1039) | ( | |
| SAMtools (v. 1.7) | ( | |
| Picard-tools (v. 1.77) | Unpublished | |
| PRINSEQ (v. 0.20.4) | ( | |
| SeqPurge (v. 2020_03-159-g5c8b2e82) | ( | |
| STAR (v. 2.7.5a) | ( | |
| RSEM (v1.3.0) | ( | |
| STARChip (v. 1.3e) | ( | |
| Cytoscape (v. 3.7.2) | ( | |
| FactoMineR R package (v. 2.4) | ( | |
| DESeq2 R package (v. 1.30.1) | ( | |
| EDASeq R package (v. 2.24.0) | ( | |
| Gene filtering procedure to increase detection power of differential expression analysis | ( | |
| Enrichr | ( | |
| TargetScan 7.1 | ( | |
| miRDB | ( | |
| Perl scripts for subtraction of circRNA counts from total RNA | ( | |
| 1 | 396700 | 396905 | ENSRNOG00000046319:AABR07000046.1 |
| 1 | 397780 | 397788 | ENSRNOG00000046319:AABR07000046.1 |
| 1 | 399062 | 399070 | ENSRNOG00000046319:AABR07000046.1 |
| 1 | 399557 | 399827 | ENSRNOG00000046319:AABR07000046.1 |
| 1 | 400256 | 401059 | ENSRNOG00000046319:AABR07000046.1 |
| 1 | 401912 | 402136 | ENSRNOG00000046319:AABR07000046.1 |
| 2 | 230660664 | 230660669 |
| 2 | 230660675 | 230662084 |
| ENSRNOG00000000001:AABR07013255.1 | ||
| …… | ||
| chr10 | 101667886 | 101667980 | ENSG00000107829:FBXW4:chr10:101667886:101676436 |
| chr10 | 101672915 | 101673047 | ENSG00000107829:FBXW4:chr10:101667886:101676436 |
| chr10 | 101673488 | 101673673 | ENSG00000107829:FBXW4:chr10:101667886:101676436 |
| 10 | 16724062 | 16730140 | Crebrf:ENSRNOG00000020769 |
| 10 | 51724607 | 51739115 | Myocd:ENSRNOG00000003669 |
| 1 | 116642079 | 116660509 | Ube3a:ENSRNOG00000015734 |
| 1 | 126573474 | 126583015 | Tm2d3:ENSRNOG00000011290 |
| … | |||